Related Experiment Videos
[Psychiatric disorders during pregnancy and lactation]
Jan Øystein Berle1, Olav Spigset
1Regionsenter for barne- og ungdomspsykiatri, Helseregion Vest, Postboks 7800, 5020 Bergen. jan.berle@psyk.uib.no
Summary
Treating psychiatric disorders during pregnancy and postpartum is crucial for maternal and infant well-being. While some medications are safe, risks must be weighed against the benefits of adequate maternal treatment.
Area of Science:
- Perinatal mental health
- Pharmacotherapy in pregnancy and lactation
- Evidence-based treatment guidelines
Context:
- Psychiatric disorders frequently occur during pregnancy and the postpartum period.
- Inadequate treatment poses significant risks to both mother and infant.
- Existing Norwegian textbooks offer limited guidance on managing these conditions.
Purpose:
- To review current knowledge on treating psychiatric disorders during pregnancy and postpartum.
- To address the challenges of pharmacotherapy in this vulnerable population.
- To inform clinical practice regarding safe and effective treatment options.
Summary:
- Drug treatment effects are better documented than other modalities.
- Some medications are safe for use during pregnancy and breastfeeding.
- Balancing maternal treatment benefits against infant risks is essential.
- Recognized pregnancy-related psychiatric illness generally has a favorable prognosis with adequate treatment.
Impact:
- Provides guidance for clinicians managing perinatal psychiatric disorders.
- Highlights the importance of risk-benefit assessment in pharmacotherapy.
- Emphasizes the need for improved educational resources on perinatal mental health treatment.